Clinical Trials Directory

Trials / Completed

CompletedNCT01734096

Renal Response to Lower Body Negative Pressure in Pre-hypertensive States

Effect of Lower Body Negative Pressure and Angiotensin II Receptor Blockade on Renal Hemodynamic, Neuro-hormonal and Tubular Response in Pre-hypertensive States: a Randomized Controlled Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
78 (actual)
Sponsor
PD Dr. Grégoire Wuerzner · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether in pre-hypertensive and hypertensive states such as white coat hypertension, obesity related hypertension or resistant hypertension, renal function is more sensitive to orthostatic stress.

Conditions

Interventions

TypeNameDescription
OTHERLower body negative pressure (LBNP)Lower limbs are put in in LBNP device for one hour (-30 mbar)
DRUGCandesartan cilexetilcandesartan cilexetil 16 mg once a day for 7 days cross over with placebo in control group, obesisty group and white coat hypertension group

Timeline

Start date
2009-05-01
Primary completion
2013-04-01
Completion
2016-04-01
First posted
2012-11-27
Last updated
2017-05-24

Locations

2 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01734096. Inclusion in this directory is not an endorsement.